RHYTHM PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.74 USD | +0.57% |
|
-3.89% | +25.60% |
| 12-03 | Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday Ahead of October JOLTS Report | MT |
| 12-03 | Rhythm Pharmaceuticals Says Imcivree Receives Expanded Marketing Authorization in UK | MT |
Chart calendar Rhythm Pharmaceuticals, Inc.
42954c04c657d61fd5f2cd2ce89024.fcUF7sAppiPerKm9iIrkmCz0Y_RiMY6PWpLZ8ASxBLk.O_Ax3aVglneyxP3zsOaD4ke9GbhaZMS_CafrgjP_YMEI8le5j3_Laq_E8A~a9c720c900c102a99e9f94ad6f1ff291
Upcoming events on Rhythm Pharmaceuticals, Inc.
Past events on Rhythm Pharmaceuticals, Inc.
| 2024-11-18 11:30 | Stifel Healthcare Conference |
| 2024-11-18 04:40 | European Society for Paediatric Endocrinology Meeting - Dr. Jesús Argente |
| 2024-11-18 04:30 | European Society for Paediatric Endocrinology Meeting - Dr. Melania Manco |
| 2024-11-17 05:10 | European Society for Paediatric Endocrinology Meeting - Dr. Jesús Argente |
| 2024-11-15 | European Society for Paediatric Endocrinology Meeting - Ahlam Azar-Kolakez |
| 2024-11-15 | European Society for Paediatric Endocrinology Meeting - Erica L. T. van den Akker |
| 2024-11-11 11:30 | Guggenheim Securities Healthcare Innovation Conference |
| 2024-11-05 17:00 | Q3 2024 Earnings Call |
| 2024-11-05 16:01 | Q3 2024 Earnings Release |
| 2024-11-04 | ObesityWeek Conference |
| 2024-09-18 14:00 | Annual General Meeting |
| 2024-09-05 15:45 | Wells Fargo Healthcare Conference |
| 2024-08-13 11:00 | CG Growth Conference |
| 2024-08-06 08:00 | Q2 2024 Earnings Call |
| 2024-08-06 07:00 | Q2 2024 Earnings Release |
| 2024-06-18 14:00 | Annual General Meeting |
| 2024-06-18 14:00 | Annual General Meeting |
| 2024-06-18 14:00 | Annual General Meeting |
| 2024-06-10 09:20 | Goldman Sachs Global Healthcare Conference - Fireside Chat |
| 2024-05-14 17:20 | BofA Securities Health Care Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,15 3,02 4.3% | 23,6 21,4 10.58% | 77,4 78,8 -1.74% | 124 | 179 | 319 |
|
EBITDA Million USD | Released Forecast Spread | -169 -161 -5.22% | -177 -177 -0.19% | -183 -179 -1.88% | -264 | -184 | -124 |
|
EBIT Million USD | Released Forecast Spread | -170 -167 -2.06% | -179 -182 1.75% | -184 -185 0.32% | -269 | -166 | -65,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -69,6 -66,6 -4.44% | -181 -184 1.68% | -184 -185 0.28% | -264 | -167 | -51,9 |
|
Net income Million USD | Released Forecast Spread | -69,6 -72,9 4.46% | -181 -184 1.5% | -185 -185 -0.05% | -266 | -167 | -52,2 |
|
EPS USD | Released Forecast Spread | -1,40 -1,46 4.24% | -3,47 -3,55 2.12% | -3,20 -3,21 0.43% | -4,35 | -2,58 | -0,76 |
| Announcement Date | 01/03/22 | 01/03/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | Settembre | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 11,5 12,1 -5.36% | 19,2 15,0 27.9% | 22,5 22,2 1.47% | 24,2 25,4 -4.51% | 26,0 26,9 -3.45% | 29,1 28,8 1% | 33,3 32,5 2.42% | 36,0 | 38,1 | 42,0 | 45,9 | 52,2 |
|
EBIT Million USD | Released Forecast Spread | -52,5 -41,3 -27.28% | -46,6 -44,1 -5.63% | -44,0 -43,9 -0.2% | -41,3 -42,3 2.45% | -140 -125 -11.74% | -40,5 -44,5 9% | -43,9 -49,5 11.42% | -46,2 | -46,7 | -46,7 | -45,6 | -41,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -52,2 -40,4 -29.08% | -46,7 -47,3 1.16% | -43,8 -43,8 -0.03% | -41,4 -43,3 4.42% | -141 -108 -30.99% | -32,3 -43,4 25.63% | -44,0 -50,0 12.03% | -47,5 | -46,6 | -43,4 | -45,8 | -45,4 |
|
Net income Million USD | Released Forecast Spread | -52,2 -40,8 -27.92% | -46,7 -44,1 -5.91% | -44,2 -44,7 1.24% | -41,6 -42,2 1.37% | -141 -122 -15.87% | -33,6 -44,1 23.87% | -45,0 -50,3 10.62% | -47,4 | -46,6 | -43,4 | -45,8 | -45,4 |
|
EPS USD | Released Forecast Spread | -0,92 -0,71 -30.37% | -0,82 -0,78 -4.63% | -0,76 -0,76 -0.16% | -0,70 -0,71 1.75% | -2,35 -2,13 -10.2% | -0,55 -0,70 21.85% | -0,73 -0,81 9.5% | -0,74 | -0,75 | -0,72 | -0,71 | -0,67 |
| Announcement Date | 02/05/23 | 01/08/23 | 07/11/23 | 22/02/24 | 07/05/24 | 06/08/24 | 05/11/24 | - | - | - | - | - |
More events
Past sector events for Rhythm Pharmaceuticals, Inc.
| 2024-12-09 06:16 | LUMOSA THERAPEUTICS CO., LTD.: November 2024 Sales and Revenue Release |
| 2024-12-05 04:03 | PHARMAESSENTIA CORPORATION: November 2024 Sales and Revenue Release |
| 2024-11-26 16:00 | ARROWHEAD PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
| 2024-11-24 | ANAVEX LIFE SCIENCES CORP.: Q4 2024 Earnings Release (Projected) |
| 2024-11-18 07:00 | IMMATICS N.V.: Q3 2024 Earnings Release |
| 2024-11-14 16:01 | CELCUITY INC.: Q3 2024 Earnings Release |
| 2024-11-14 16:01 | ASCENDIS PHARMA A/S: Q3 2024 Earnings Release |
| 2024-11-14 08:00 | ANNEXON, INC.: Q3 2024 Earnings Release |
| 2024-11-14 04:09 | PHARMAESSENTIA CORPORATION: Q3 2024 Earnings Release |
| 2024-11-13 | PEPTRON, INC.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RYTM Stock
- Calendar Rhythm Pharmaceuticals, Inc.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition